Lexaria closes $4M registered direct offering of 2.67M shares at $1.50 with warrants at $1.37

Lexaria Bioscience Corp.

Closed on Sept 29, 2025: gross proceeds of $4.0M from 2,666,667 shares at $1.50 and warrants.
Warrants for 2,666,667 shares at $1.37, immediately exercisable, 5-year term from resale registration.
Placement agent H.C. Wainwright receives 7% cash fee and 93,333 warrants at $1.875 exercise price.
Net proceeds for working capital and general corporate purposes; CEO cites 2026 R&D and BD plans.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.